Evidence map›Paper›PMID 24876872›Full record

ArticleEvidence-based complementary and alternative medicine : eCAM2014

Evaluation of Preclinical Assays to Investigate an Anthroposophic Pharmaceutical Process Applied to Mistletoe (Viscum album L.) Extracts.

Stephan Baumgartner, Heidi Flückiger, Matthias Kunz, Claudia Scherr, Konrad Urech

Open access · hybridAbstract read
In one paragraph

Article in Evidence-based complementary and alternative medicine : eCAM, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.3field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Chronobiology ofFrontiers in physiology · 2024
    Article
  4. Article
  5. Experimental and therapeutic medicine · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Stephan BaumgartnerHiscia Institute, Society for Cancer Research, Kirschweg 9, 4144 Arlesheim, Switzerland ; Institute of Integrative Medicine, Gemeinschaftskrankenhaus, University of Witten-Herdecke, Gerhard-Kienle-Weg 4, 58313 Herdecke, Germany ; Institute of Complementary Medicine, Inselspital, University of Bern, Imhoof-Pavillon, 3010 Bern, Switzerland.ORCID 0000-0001-7945-6403
Heidi FlückigerHiscia Institute, Society for Cancer Research, Kirschweg 9, 4144 Arlesheim, Switzerland.
Matthias KunzHiscia Institute, Society for Cancer Research, Kirschweg 9, 4144 Arlesheim, Switzerland.ORCID 0000-0001-8834-9140
Claudia ScherrHiscia Institute, Society for Cancer Research, Kirschweg 9, 4144 Arlesheim, Switzerland.ORCID 0000-0003-1154-0195
Konrad UrechHiscia Institute, Society for Cancer Research, Kirschweg 9, 4144 Arlesheim, Switzerland.ORCID 0000-0001-6715-3579
Verein für Krebsforschung · CHUniversity of Bern · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Extracts from European mistletoe (Viscum album L.) developed in anthroposophic medicine are based on specific pharmaceutical procedures to enhance remedy efficacy. One such anthroposophic pharmaceutical process was evaluated regarding effects on cancer cell toxicity in vitro and on colchicine tumor formation in Lepidium sativum. Anthroposophically processed Viscum album extract (APVAE) was produced by mixing winter and summer mistletoe extracts in the edge of a high-speed rotating disk and was compared with manually mixed Viscum album extract (VAE). The antiproliferative effect of VAE/APVAE was determined in five cell lines (NCI-H460, DU-145, HCC1143, MV3, and PA-TU-8902) by WST-1 assay in vitro; no difference was found between VAE and APVAE in any cell line tested (P > 0.14). Incidence of colchicine tumor formation was assessed by measurement of the root/shoot-ratio of seedlings of Lepidium sativum treated with colchicine as well as VAE, APVAE, or water. Colchicine tumor formation decreased after application of VAE (-5.4% compared to water, P < 0.001) and was even stronger by APVAE (-8.8% compared to water, P < 0.001). The high-speed mistletoe extract mixing process investigated thus did not influence toxicity against cancer cells but seemed to sustain morphostasis and to enhance resistance against external noxious influences leading to phenomenological malformations.

Identifiers

PMID24876872
PMCPMC4024402
OpenAlexW2016538348

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.